Skip to main content
Premium Trial:

Request an Annual Quote

Alnylam Licenses Kreutzer-Limmer Patents to Shanghai GenePharma

NEW YORK (GenomeWeb News) – Alnylam Pharmaceuticals announced today that it has granted a non-exclusive, worldwide license to Shanghai GenePharma, allowing the Chinese siRNA supplier to manufacture and sell RNAi products and services covered by Alnylam-owned patents for research purposes.
 
Alnylam owns exclusive rights to many RNAi structural properties and applications — for instance, in mammalian cells — under the Kreutzer-Limmer patent family. This license allows Shanghai GenePharma to provide these research tools to the pharmaceutical and research community in China and beyond.
 
As of last October, Alnylam had licensed its intellectual property to three other research product suppliers in Asia and 15 worldwide. That number has now climbed to more than 16 license agreements, according to Alnylam Vice President of Business Development Jason Rhodes.
 
“Providing this license to Shanghai GenePharma represents our first business transaction in China, which is regarded as having one of the fastest growing life science markets in the world,” Rhodes said in a statement.
 
Financial terms of the agreement were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.